Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Neyns B et al. - Cetuximab was well tolerated but had limited activity in this patient population with progressive HGG. A minority of patients may derive a more durable benefit but were not prospectively identified by EGFR gene copy number.

Related Articles

Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT
Journal of Neuro-Oncology, 10/30/09    Relevance Score: 68%

A Phase II Study of Cisplatin and Temozolomide in Heavily Pre-treated Patients with Temozolomide-refractory High-grade Malignant Glioma
Anticancer Research, 11/13/09    Relevance Score: 66%

Treatment of recurrent high-grade gliomas
Current Opinion in Neurology, 11/12/09    Relevance Score: 66%

Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas
Neuro-Oncology, 10/05/09    Relevance Score: 66%

Data Presented On Oncophage Cancer Vaccine In Recurrent Glioma At SNO 2009
Antigenics, 10/30/09    Relevance Score: 65%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address